亚洲在线日韩伦理片,96精品国产AⅤ一区二区,青鸟影视网,yy黄色频道,国内精品久久久精品AV电影院

東曜藥業有限公司 BioDlink Biopharm Co., Ltd.

Latest News

BioDlink's Bevacizumab Approved for Market Launch in Indonesia, Marking Fourth Consecutive Emerging Market Authorization

 * Bevacizumab Injection officially approved by Indonesia's National Agency of Drug and Food Contr...

2025-08-21 20:00 1306

BioDlink Accelerates Global Expansion with Bevacizumab Launch in Colombia and Pakistan

 - BioDlink's bevacizumab injection secures marketing authorization?in?Colombia andPakistan followin...

2025-08-13 20:00 1518

BioDlink's Bevacizumab Approved for Market Launch in Nigeria, Accelerating Global Expansion

 * BioDlink's Bevacizumab Injection has been granted marketing authorization by Nigeria's National ...

2025-06-16 20:30 1429

BioDlink Strengthens Global Compliance with Argentina GMP Certification

 * Global Milestone: GMP certification from Argentina, marking a key step in its global expansion ...

2025-06-05 20:30 1712

BioDlink Clinches Brazil GMP Audit to Strengthen Emerging Markets Growth

 * International recognition of quality system with GMP-compliance in the key markets ofBrazil, In...

2025-05-21 20:30 1805

BioDlink Congratulates Junshi Biosciences on IND Approval of JS212, a Bispecific ADC Therapeutic Candidate

 * BioDlink congratulates Junshi Biosciences on receiving IND approval from China's NMPA for JS212...

2025-05-08 20:30 4045

SUCCESSFUL PASSING OF EU QP AUDIT ON TOT BIOPHARM'S COMMERCIAL PRODUCTION BASE FOR MONOCLONAL ANTIBODY DRUG SUBSTANCES AND ANTIBODY DRUG CONJUGATES

 SUZHOU,China, Oct. 27, 2022 /PRNewswire/ -- TOT BIOPHARM International Company Limited (TOT BIOPHAR...

2022-10-27 08:00 3118

Connected Transactions Involving Subscription by Vivo Suzhou Fund and Centerlab for TOT BIOPHARM Shares

 SUZHOU, China, June 2, 2022 /PRNewswire/ -- On June 1, 2022, TOT BIOPHARM International Company Lim...

2022-06-02 08:00 6513

TOT BIOPHARM Announces NMPA Granted Marketing Approval for Pusintin? (TAB008, Bevacizumab Injection) in China

 SUZHOU, China, Dec. 2, 2021 /PRNewswire/ -- TOT BIOPHARM International Company Limited (TOT BIOPHAR...

2021-12-02 08:00 3213

TOT BIOPHARM Anounces 2021 Interim Results

 Revenue Surges 78% to RMB23.13 million CDMO Business Achieves Leapfrog Breakthrough Two Products App...

2021-08-13 10:59 20117